Ata, Rica M.

HRN: 26-19-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2026
CEFUROXIME 500MG (TAB)
05/02/2026
05/07/2026
PO
500
BID
Thickly Msaf
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: